While the connection between inflammation and depression is still under investigation, our data highlight a new translational control pathway, which may underlie the chronic antidepressant action of SSRIs and could be exploited to design novel antidepressants by boosting eIF4E phosphorylation (Fig. 7C). This evidence concerns the gene EIF4E and major depressive disorder.